Tau filament formation in transgenic mice expressing P301L tau.
about
Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradationRapid neurofibrillary tangle formation after localized gene transfer of mutated tauPin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?Mouse models of frontotemporal dementiaPhysiological and pathological phosphorylation of tau by Cdk5Tau-targeted treatment strategies in Alzheimer's diseaseTau physiology and pathomechanisms in frontotemporal lobar degenerationACAT1/SOAT1 as a therapeutic target for Alzheimer's diseaseCSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's diseaseAnimal models for Alzheimer's disease and frontotemporal dementia: a perspectiveTau suppression in a neurodegenerative mouse model improves memory functionAlzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's diseaseDetailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic miceHyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment.Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model.Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options.Targeting Abeta and tau in Alzheimer's disease, an early interim reportTransgenic models of Alzheimer's disease: learning from animalsConvergence of amyloid-beta and tau pathologies on mitochondria in vivo.Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons.Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For TauopathiesSodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease modelsStaging of Alzheimer's pathology in triple transgenic mice: a light and electron microscopic analysis.Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice.Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy.Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.Probing the biology of Alzheimer's disease in mice.Role for glyoxalase I in Alzheimer's disease.The cytoskeleton in neurodegenerative diseases.Drosophila melanogaster as a model organism for Alzheimer's disease.Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles.Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease.Tumor suppressor PTEN affects tau phosphorylation: deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau.Granular expression of prolyl-peptidyl isomerase PIN1 is a constant and specific feature of Alzheimer's disease pathology and is independent of tau, Aβ and TDP-43 pathologyCharacterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.Profiling murine tau with 0N, 1N and 2N isoform-specific antibodies in brain and peripheral organs reveals distinct subcellular localization, with the 1N isoform being enriched in the nucleus.Fragmentation of the Golgi apparatus induced by the overexpression of wild-type and mutant human tau forms in neurons.
P2860
Q24305254-ABF59AA9-66D7-41AC-86C8-5EB793553E74Q24675907-98A59D0C-AD3F-4A20-A212-DB6875198C73Q24684898-B0AB8B11-5615-4EB5-918E-FD0003C5EA53Q26829009-87C00CF7-6D88-4F05-A42F-238DA17F86C7Q26860395-0027241D-C0DE-4BC3-BDD1-82B8958AEAE6Q27023429-E392F1F1-827E-4102-80B2-32C3862A5226Q28070250-DEBFF053-CDC8-4033-AD04-56812F5357C2Q28081654-3B3DA4ED-0A88-4738-8B36-8F6B266BA83EQ28728773-7EB0A34D-A139-497D-81AD-B66D0B5EA050Q28749702-4E7E2A1F-63DA-40A7-B38B-65564222DEA7Q29615831-A3F35D69-19F9-4BBB-AD4A-2CDE540DB684Q30478477-0E0B766A-7740-4131-A3E6-0185FFEF8654Q30480000-0111A00C-0B6A-4FE4-BD7C-8024ED0E948CQ30913572-06300EFB-3CF8-41D9-96DF-0ABEC5041DF5Q33359744-F5E36A6F-C650-4F92-B1E3-8BA034F48A4DQ33559266-5732FCD2-9AB3-4CCE-BCB6-D45264926598Q33603862-F52F0394-6E6C-4C28-8DF4-446BDE9269B3Q33761048-5FB28EB2-7CFA-4453-BC0B-FBD2992A5000Q33829008-765B590B-A275-42A4-94E2-BA245CE841BAQ33844718-BF9A5826-DA46-4D1E-AC4A-70829985A34AQ33876147-7A1A3B81-DE04-4E13-AB29-29A0D36D2AD3Q33987984-4C009B9D-DD0F-43F2-8242-A1636F78653FQ34001049-1F76B1F9-0E6F-4AAF-8687-B1603EBEC593Q34068459-5D7B9275-DE6E-4954-ABCF-32D10DD0268CQ34078130-2A33D253-03C7-41A3-A377-E30367DC7508Q34102829-B529F2A2-24F6-419B-8679-DABA1653EDBEQ34127161-880AA5BB-17CA-48ED-8D69-3DA630808457Q34162119-8E81A89E-E49A-4916-92C9-7AFB30540EF0Q34206962-0177904B-7B28-4E98-9EFD-1FBEBB64ABEBQ34336935-AA6B5C88-4BD4-40A0-9706-9671EDD10693Q34446779-C96FE7DA-B6C2-4FC8-8A9F-3385B48E7114Q34464181-6B508F7D-B3AB-475B-968B-BBBE1C4B90E9Q34629320-0E0DBD4A-A045-4B0C-B8A6-2A93551681E7Q34869120-12A515CF-9737-407E-A9A4-D5C9AC46207BQ34903853-39205329-EF3E-4E90-9A98-CBC162849C44Q35016068-BFF040C0-01B2-466D-9714-7BB57E586373Q35064814-5E7DF380-75DF-4053-8305-57A25C6AD721Q35067755-1297C7FD-ED44-4FD9-B93B-68512746F3A3Q35081058-2076DCCC-5087-4DDA-935D-C3EE10D29999Q35087803-6F5FB085-899D-40C2-B19E-AB7252C4C30B
P2860
Tau filament formation in transgenic mice expressing P301L tau.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Tau filament formation in transgenic mice expressing P301L tau.
@ast
Tau filament formation in transgenic mice expressing P301L tau.
@en
type
label
Tau filament formation in transgenic mice expressing P301L tau.
@ast
Tau filament formation in transgenic mice expressing P301L tau.
@en
prefLabel
Tau filament formation in transgenic mice expressing P301L tau.
@ast
Tau filament formation in transgenic mice expressing P301L tau.
@en
P2093
P2860
P356
P1476
Tau filament formation in transgenic mice expressing P301L tau
@en
P2093
P2860
P304
P356
10.1074/JBC.M006531200
P407
P50
P577
2001-01-01T00:00:00Z